loadpatents
Patent applications and USPTO patent grants for Chernykh; Yulia Sergeevna.The latest application filed is for "monoclonal antibody to pd-l1".
Patent | Date |
---|---|
Method for treatment of an IL-17A-mediated disease through antibody administration specific to human IL-17A Grant 11,447,574 - Ulitin , et al. September 20, 2 | 2022-09-20 |
Monoclonal antibody to PD-L1 Grant 11,236,167 - Ulitin , et al. February 1, 2 | 2022-02-01 |
Anti-PD-1 antibodies, method for producing same and method for using same Grant 11,136,408 - Ekimova , et al. October 5, 2 | 2021-10-05 |
Monoclonal Antibody To Pd-l1 App 20200369771 - ULITIN; Andrey Borisovich ;   et al. | 2020-11-26 |
High Affinity And Aggregatively Stable Antibodies On The Basis Of Variable Domains Vl And A Derivative Vhh App 20200031952 - ULITIN; Andrey Borisovich ;   et al. | 2020-01-30 |
Antibody Or An Antigen-binding Fragment Thereof Capable Of Binding To A Human Receptor Of Interleukin-6 App 20190194313 - EVDOKIMOV; Stanislav Rudolfovich ;   et al. | 2019-06-27 |
Anti-pd-1 Antibodies, Method For Producing Same And Method For Using Same App 20190127478 - EKIMOVA; Viktoriia Mikhailovna ;   et al. | 2019-05-02 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.